COPD Therapeutics in Major Developed Markets to 2021 - Emergence of Addition-in-Class and First-in-Class Products Offsets Sales Erosion of Leading Brands

Market: Pharmaceuticals and Healthcare

Global, 122 pages report, published by GBI Research

Report ThumbnailNovember-2015
COPD Therapeutics in Major Developed Markets to 2021 - Emergence of Addition-in-Class and First-in-Class Products Offsets Sales Erosion of Leading Brands

Summary

Chronic Obstructive Pulmonary Disease (COPD) is a progressive disorder associated with chronic inflammation of the airways and lungs. Persistent breathing difficulties and repeated exacerbations of COPD symptoms make the disease one of the leading causes of morbidity, and the fifth-leading cause of death in the world. COPD is linked t

Read More
  • 1.2 List of Figures
  • Figure 1: COPD Market, Global, Marketed Products Heat Map, Moderate to Severe, Efficacy, 2015 17
  • Figure 2: COPD Market, Global, Marketed Products Heat Map, Moderate to Severe, Safety, 2015 18
  • Figure 3: COPD Market, Global, Marketed Products Heat Map, Very Severe, Efficacy, 2015 19
  • Figure 4: COPD Market, Global, Marketed Products Heat Map, Very Severe, Safety, 2015 20
  • Figure 5: COPD Market, Global, Pipeline, 2015 34
  • Figure 6: COPD Market, Global, Pipeline, Molecular Target, 20
Read More
  • 1.1 List of Tables
  • Table 1: COPD Market, Disease Severity, 2015 11
  • Table 2: COPD Market, Patient Risk Categories, 2015 12
  • Table 3: COPD Market, Treatment Algorithm, 2015 14
  • Table 4: COPD Market, Global, Pipeline Products, Discovery, 2015 92
  • Table 5: COPD Market, Global, Pipeline Products, Preclinical, 2015 94
  • Table 6: COPD Market, Global, Pipeline Products, Phase I, 2015 99
  • Table 7: COPD Market, Global, Pipeline Products, Phase II, 2015 101
  • Table 8: COPD Market, Global, Pipeline Products, Phase
Read More
  • 1 Table of Contents
  • 1 Table of Contents 5
  • 1.1 List of Tables 7
  • 1.2 List of Figures 7
  • 2 Introduction 9
  • 2.1 Disease Introduction 9
  • 2.2 Symptoms 9
  • 2.3 Etiology 9
  • 2.4 Pathophysiology 10
  • 2.5 Diagnosis 10
  • 2.6 Assessment of Disease Severity 11
  • 2.7 Treatment 12
  • 2.8 Treatment Algorithm 14
  • 2.8.1 Mild COPD 14
  • 2.8.2 Moderate-to-Severe COPD 15
  • 2.8.3 Very Severe COPD 16
  • 2.8.4 Marketed Products Heat Map 17
  • 3 Marketed Products 21
  • 3.1 Product Profiles 22
  • 3.1.1 Bronchodilator and Inhaled Corticosteroid Combinatio
Read More

Please select a license type

Share

Related Products

GBI ResearchCOPD Therapeutics in Major Developed Markets to 2021 - Emergence of Addition-in-Class and First-in-Class Products Offsets Sales Erosion of Leading BrandsProduct ThumbnailCOPD Therapeutics in Major Developed Markets to 2021 - Emergence of Addition-in-Class and First-in-Class Products Offsets Sales Erosion of Leading Brands, Industry ReportProduct #: 135875
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2020 Global Market Analyst. All Rights Reserved